Stephen Cornelissen AM
Stephen Cornelissen AM is the CEO of Lifeblood, who recognized the enduring legacy of James Harrison, noting the ongoing research efforts to replicate Harrison's unique antibodies for the development of artificial Anti-D, which aims to prevent hemolytic disease in newborns worldwide.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Vietnam:
Stephen Cornelissen AM, the CEO of Lifeblood, stated that James's legacy continues even after his passing.
9